-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, MvrdxgCgKOomoN+2JrVIFLa/ki20n2PCWbZBRF/w8aRdesJCHLF23PmOEGFz8hgV aucKgDn5rDYPumbdu1cvSg== 0001193125-06-030599.txt : 20060214 0001193125-06-030599.hdr.sgml : 20060214 20060214114530 ACCESSION NUMBER: 0001193125-06-030599 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20060214 DATE AS OF CHANGE: 20060214 GROUP MEMBERS: DORSET MANAGEMENT CORPORATION FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: KNOTT DAVID M CENTRAL INDEX KEY: 0000808722 FILING VALUES: FORM TYPE: SC 13G/A MAIL ADDRESS: STREET 1: 485 UNDERHILL BLVD STREET 2: STE 205 CITY: SYOSSET STATE: NY ZIP: 11791-3419 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: NEOPHARM INC CENTRAL INDEX KEY: 0000942788 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 510327886 STATE OF INCORPORATION: DE FISCAL YEAR END: 0907 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-49245 FILM NUMBER: 06609385 BUSINESS ADDRESS: STREET 1: 150 FIELD DRIVE STREET 2: SUITE 195 CITY: LAKE FORREST STATE: IL ZIP: 60045 BUSINESS PHONE: 8472958678 MAIL ADDRESS: STREET 1: C/O WILSON SONSIN GOODRICH & ROSETI STREET 2: 650 PAGE MILL ROAD CITY: PALO ALTO STATE: CA ZIP: 94304 SC 13G/A 1 dsc13ga.htm AMENDMENT NO. 3 TO SCHEDULE 13G Amendment No. 3 to Schedule 13G

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

SCHEDULE 13G

 

 

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT

TO RULES 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED

PURSUANT TO RULE 13d-2(b)

(Amendment No. 3)1

 

 

 

NeoPharm, Inc.


(Name of Issuer)

 

Common Stock, $0.0002145 Par Value


(Title of Class of Securities)

 

 

640919106


                                (CUSIP Number)                                

 

December 31, 2005


(Date of Event Which Requires Filing of this Statement)

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

¨ Rule 13d-1(b)

 

x Rule 13d-1(c)

 

¨ Rule 13d-1(d)

 

1   The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

 

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (the “Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).


CUSIP No. 640919106

   13G    Page 2 of 6 Pages

 

  1.  

NAME OF REPORTING PERSONS

I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)

 

            David M. Knott

   
  2.  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

(a)  ¨

(b)  x

   
  3.  

SEC USE ONLY

 

   
  4.  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

            United States of America

   

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

 

  5.    SOLE VOTING POWER:

 

                1,908,138


  6.    SHARED VOTING POWER:

 

                104,200


  7.    SOLE DISPOSITIVE POWER:

 

                 2,034,838


  8.    SHARED DISPOSITIVE POWER:

 

                0

  9.  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON:

 

            2,034,838

   
10.  

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*

 

 

¨

 

11.  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

 

            8.6%

   
12.  

TYPE OF REPORTING PERSON*

 

            IN

   

 

* SEE INSTRUCTIONS BEFORE FILLING OUT!

 

2


CUSIP No. 640919106

   13G    Page 3 of 6 Pages

 

  1.  

NAME OF REPORTING PERSONS

I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)

 

            Dorset Management Corporation

            11-2873658

   
  2.  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

(a)  ¨

(b)  x

   
  3.  

SEC USE ONLY

 

   
  4.  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

            New York

   

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

 

  5.    SOLE VOTING POWER:

 

                1,908,138


  6.    SHARED VOTING POWER:

 

                 104,200


  7.    SOLE DISPOSITIVE POWER:

 

                 2,034,838


  8.    SHARED DISPOSITIVE POWER:

 

                0

  9.  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON:

 

            2,034,838

   
10.  

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*

 

 

¨

 

11.  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

 

            8.6%

   
12.  

TYPE OF REPORTING PERSON*

 

            CO

   

 

* SEE INSTRUCTIONS BEFORE FILLING OUT!

 

3


Item 1

 

(a)

   Name of Issuer:          
         NeoPharm, Inc.          

Item 1

 

(b)

   Address of Issuer’s Principal Executive offices:          
         150 Field Drive          
         Suite 195          
         Lake Forest, IL 60045          

Item 2

 

(a)

   Name of Person(s) Filing:          
         David M. Knott; Dorset Management Corporation          

Item 2

 

(b)

   Address(es) of Principal Business Office or, if none, residence:          
         485 Underhill Boulevard, Suite 205          
         Syosset, New York 11791          

Item 2

 

(c)

   Citizenship or Place of Organization          
         David M. Knott - United States of America;          
         Dorset Management Corporation – New York          

Item 2

 

(d)

   Title of Class of Securities:          
         Common Stock, $0.0002145 Par Value          

Item 2

 

(e)

   CUSIP Number:          
         640919106          

Item 3

  If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a:     
    (a)    ¨    Broker or dealer registered under Section 15 of the Exchange Act;
    (b)    ¨    Bank as defined in Section 3(a)(6) of the Exchange Act;
    (c)    ¨    Insurance company as defined in Section 3(a)(19) of the Exchange Act;
    (d)    ¨    Investment company registered under Section 8 of the Investment Company Act;
    (e)    ¨    An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);
    (f)    ¨    An employee benefit plan, or endowment fund in accordance with rule 13d-1(b)(l)(ii)(F);
    (g)    ¨    A parent holding company, or control person, in accordance with Rule 13d-1(b)(1)(ii)(G);
    (h)    ¨    A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act;
    (i)    ¨    A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act;
    (j)    ¨    Group, in accordance with Rule 13d-1(b)(1)(ii)(J).

 

4


Item 4

   Ownership:          
     David M. Knott; Dorset Management Corporation          
     See Rows 5 through 9 and 11 on the corresponding page for each reporting person.          

Item 5

   Ownership of Five Percent or Less of a Class     
     N/A     

Item 6

   Ownership of More than Five Percent on Behalf of Another Person          
     Persons, other than the Reporting Persons hereunder, have the right to receive or the power to direct the receipt of dividends, or the proceeds from the sale, of the securities reported herein.          

Item 7

   Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company
     N/A

Item 8

   Identification and Classification of Members of the Group          
     N/A          

Item 9

   Notice of Dissolution of Group          
     N/A          

Item 10

   Certification          
     By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.          

 

5


After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

February 14, 2006


Date

/s/ David M. Knott


David M. Knott

 

DORSET MANAGEMENT CORPORATION
By:  

/s/ David M. Knott


   

David M. Knott,

President

 

6

-----END PRIVACY-ENHANCED MESSAGE-----